Assertio Holdings Set for Key Investor Conferences
LAKE FOREST, Ill. — Assertio Holdings, Inc. (Nasdaq: ASRT) has exciting news for the investment community. The company announced its participation in two significant investor conferences in New York City this September. This strategic engagement aims to strengthen relationships with investors and highlight the company's commitment to innovation in healthcare.
Details of the Investor Conferences
The first key event on Assertio's calendar is the HC Wainwright Conference, scheduled for September 10. Taking place at the prestigious Lotte New York Palace Hotel, this conference offers a unique platform for management to conduct investor meetings. Attendees are encouraged to register and arrange meetings through their HC Wainwright representatives, providing an opportunity for direct dialogue and in-depth discussions.
Overview of the HC Wainwright Conference
This conference is renowned for bringing together prominent investors and management teams from various industries. Assertio’s participation will certainly foster engaging conversations about their recent advancements, pipeline products, and strategic vision for the future. Investors looking to gain insights into the company’s trajectory can look forward to impactful sessions led by Assertio's leadership.
Participation in the Lake Street Capital Markets BIG9 Conference
Following the HC Wainwright event, Assertio will also participate in the Lake Street Capital Markets BIG9 Conference on September 11, hosted at the Yale Club in New York City. Similar to the previous event, investors can register through Lake Street representatives to secure meetings with Assertio’s management team.
Importance of the Lake Street Capital Markets Conference
As another vital gathering for investors, the BIG9 Conference provides a space for sharing insights on market dynamics and exploring innovative solutions in the pharmaceutical sector. Assertio's presence here underscores its position as a forward-thinking company committed to addressing patients' needs through its diverse product offerings in oncology, neurology, and pain management.
About Assertio Holdings
Assertio is dedicated to delivering specialized pharmaceutical solutions designed to meet patients’ needs. The company takes pride in its comprehensive approach to marketing products that significantly impact patient care. Through rigorous research and development, Assertio aims to enhance treatment options in critical areas such as oncology and neurology.
Company Vision and Future Directions
Continuing its commitment to excellence, Assertio actively seeks opportunities to expand its portfolio of differentiated products. By leveraging its commercial capabilities, Assertio strives to lead the forefront of innovation within the pharmaceutical industry, ensuring that patients receive the best possible care.
Contact Information for Investors
For any inquiries regarding investor relations, individuals can reach out to Matt Kreps, Managing Director at Darrow Associates. He is available via mobile at 214-597-8200. Additionally, investors may contact him through email for further assistance.
Frequently Asked Questions
What is the purpose of Assertio's participation in these conferences?
The participation aims to foster connections with investors and share insights about the company's ongoing developments and future strategies.
Where will the HC Wainwright Conference be held?
The HC Wainwright Conference is scheduled to take place at the Lotte New York Palace Hotel.
How can investors register for the conferences?
Investors interested in attending can register and arrange meetings through their respective conference representatives.
What focus areas does Assertio target in its product offerings?
Assertio focuses on oncology, neurology, and pain management, with a commitment to marketing differentiated therapeutic options.
Who should investors contact for more information?
Investors can reach out to Matt Kreps at Darrow Associates for any inquiries regarding their participation and the company’s direction.
